v3.26.1
BASIS OF PRESENTATION (Details 2) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating activities    
Net income (loss) $ 3,229,957 $ (15,979,351)
Adjustments for non-cash items in net loss:    
Depreciation of property and equipment 702,258 993,379
Depreciation of property and equipment included in costs of finished cannabis inventory sold 2,140,694 436,047
Lease costs included in costs of finished cannabis inventory sold 549,964 328,957
Share-based compensation 2,393,994 1,608,823
Unrealized (gain) loss on derivative liability (44,917) 7,754,402
Realized loss on derivative liability (5,859,744) 5,049,209
Unrealized (gain) loss on warrant asset (247,477) (3,094,413)
Realized loss on warrant liability 1,741,710
Loss on equity investment in associate 452,962 251,230
Loss on disposal of property and equipment (50,057)
Deferred income taxes (1,121,618) (1,379,093)
Changes in non-cash working capital 12,897 1,850,802
Net cash provided by operating activities 3,569,795 2,614,980
Investing activities    
Purchase of property and equipment (4,659,006) (4,082,154)
Acquisition of Golden Harvests LLC (437,375)
Acquisition of Canopy Management, LLC (173,157) (271,438)
Dividend issued from Golden Harvests, LLC to minority owner (115,000) (530,000)
Advance of notes receivable (250,000) (1,547,678)
Repayment of notes receivable 266,417
Investment in ABCO Garden State, LLC (1,980,000)
Cash acquired on investment in ABCO Garden State, LLC 2,815
Advance on purchase of remaining Rogue EBC, LLC equity interest (1,235,855) (827,197)
Net cash used in investing activities (6,870,393) (8,969,235)
Financing activities    
Proceeds from exercise of stock options 406,944 359,958
Proceeds from long-term debt 12,630,345 450,000
Debt issuance costs (739,313) (126,914)
Payment of interest on convertible debentures (79,755) (453,439)
Proceeds from sale of units of subsidiary 787,500
Net cash provided by financing activities 9,750,700 4,485,245
Effect of foreign exchange on cash and cash equivalents 4,024 (17,861)
Change in cash and cash equivalents 6,454,126 (1,886,871)
Cash and cash equivalents, beginning of year 4,917,708 6,804,579
Cash and cash equivalents, ending of year 11,371,834 4,917,708
IFRS [Member]    
Operating activities    
Net income (loss)   (10,696,794)
Adjustments for non-cash items in net loss:    
Depreciation of property and equipment   939,727
Depreciation of property and equipment included in costs of finished cannabis inventory sold   1,980,597
Lease costs included in costs of finished cannabis inventory sold  
Unrealized fair value gain amounts on growth of biological assets   (2,816,943)
Realized fair value loss amounts in inventory sold   3,358,862
Share-based compensation   1,306,607
Accretion expense   2,042,556
Unrealized (gain) loss on derivative liability   12,768,905
Unrealized (gain) loss on warrant asset   3,094,414
Realized loss on warrant liability  
Loss on equity investment in associate   169,637
Loss on disposal of property and equipment   (50,057)
Gain on extinguishment of notes receivable   (156,165)
Deferred income taxes   (4,326)
Currency translation loss   (17,861)
Changes in non-cash working capital   1,394,111
Net cash provided by operating activities   7,124,442
Investing activities    
Purchase of property and equipment   (1,739,014)
Acquisition of Golden Harvests LLC   (529,998)
Acquisition of Canopy Management, LLC   (271,438)
Dividend issued from Golden Harvests, LLC to minority owner   (530,000)
Advance of notes receivable   (7,898,136)
Repayment of notes receivable   484,160
Investment in ABCO Garden State, LLC   (1,980,000)
Cash acquired on investment in ABCO Garden State, LLC  
Repayment of bridge note   266,417
Advance on purchase of remaining Rogue EBC, LLC equity interest  
Net cash used in investing activities   (12,198,009)
Financing activities    
Proceeds from exercise of stock options   359,958
Proceeds from exercise of warrants   4,657,460
Proceeds from long-term debt  
Debt issuance costs   (126,914)
Repayment of long-term debt   (1,230,093)
Payment of interest on convertible debentures   (521,953)
Proceeds from sale of units of subsidiary   787,500
Payment of lease liability   (974,749)
Net cash provided by financing activities   2,951,209
Effect of foreign exchange on cash and cash equivalents  
Change in cash and cash equivalents   (2,122,358)
Cash and cash equivalents, beginning of year 4,682,221 6,804,579
Cash and cash equivalents, ending of year   4,682,221
Effect of transition to U.S. GAAP [Member]    
Operating activities    
Net income (loss)   (5,282,557)
Adjustments for non-cash items in net loss:    
Depreciation of property and equipment   53,652
Depreciation of property and equipment included in costs of finished cannabis inventory sold   (1,544,550)
Lease costs included in costs of finished cannabis inventory sold   328,957
Unrealized fair value gain amounts on growth of biological assets   2,816,943
Realized fair value loss amounts in inventory sold   (3,358,862)
Share-based compensation   302,216
Accretion expense   (206,116)
Unrealized (gain) loss on derivative liability   (5,014,503)
Realized loss on derivative liability   (5,049,209)
Unrealized (gain) loss on warrant asset   (1)
Realized loss on warrant liability   1,741,710
Loss on equity investment in associate   81,593
Loss on disposal of property and equipment  
Gain on extinguishment of notes receivable   156,165
Deferred income taxes   (107,872)
Currency translation loss   17,861
Changes in non-cash working capital   456,691
Net cash provided by operating activities   (4,509,462)
Investing activities    
Purchase of property and equipment   (2,343,140)
Acquisition of Golden Harvests LLC   529,998
Acquisition of Canopy Management, LLC  
Dividend issued from Golden Harvests, LLC to minority owner  
Advance of notes receivable   6,350,458
Repayment of notes receivable   (217,743)
Investment in ABCO Garden State, LLC  
Cash acquired on investment in ABCO Garden State, LLC   2,815
Repayment of bridge note   (266,417)
Advance on purchase of remaining Rogue EBC, LLC equity interest   (827,197)
Net cash used in investing activities   3,228,774
Financing activities    
Proceeds from exercise of stock options  
Proceeds from exercise of warrants   (47,883)
Proceeds from long-term debt   450,000
Debt issuance costs  
Repayment of long-term debt   88,656
Payment of interest on convertible debentures   68,514
Proceeds from sale of units of subsidiary  
Payment of lease liability   974,749
Net cash provided by financing activities   1,534,036
Effect of foreign exchange on cash and cash equivalents   (17,861)
Change in cash and cash equivalents   235,487
Cash and cash equivalents, beginning of year 235,487
Cash and cash equivalents, ending of year   235,487
U.S. GAAP [Member]    
Operating activities    
Net income (loss)   (15,979,351)
Adjustments for non-cash items in net loss:    
Depreciation of property and equipment   993,379
Depreciation of property and equipment included in costs of finished cannabis inventory sold   436,047
Lease costs included in costs of finished cannabis inventory sold   328,957
Unrealized fair value gain amounts on growth of biological assets  
Realized fair value loss amounts in inventory sold  
Share-based compensation   1,608,823
Accretion expense   1,836,440
Unrealized (gain) loss on derivative liability   7,754,402
Realized loss on derivative liability   (5,049,209)
Unrealized (gain) loss on warrant asset   3,094,413
Realized loss on warrant liability   1,741,710
Loss on equity investment in associate   251,230
Loss on disposal of property and equipment   (50,057)
Gain on extinguishment of notes receivable  
Deferred income taxes   (112,198)
Currency translation loss  
Changes in non-cash working capital   1,850,802
Net cash provided by operating activities   2,614,980
Investing activities    
Purchase of property and equipment   (4,082,154)
Acquisition of Golden Harvests LLC  
Acquisition of Canopy Management, LLC   (271,438)
Dividend issued from Golden Harvests, LLC to minority owner   (530,000)
Advance of notes receivable   (1,547,678)
Repayment of notes receivable   266,417
Investment in ABCO Garden State, LLC   (1,980,000)
Cash acquired on investment in ABCO Garden State, LLC   2,815
Repayment of bridge note  
Advance on purchase of remaining Rogue EBC, LLC equity interest   (827,197)
Net cash used in investing activities   (8,969,235)
Financing activities    
Proceeds from exercise of stock options   359,958
Proceeds from exercise of warrants   4,609,577
Proceeds from long-term debt   450,000
Debt issuance costs   (126,914)
Repayment of long-term debt   (1,141,437)
Payment of interest on convertible debentures   (453,439)
Proceeds from sale of units of subsidiary   787,500
Payment of lease liability  
Net cash provided by financing activities   4,485,245
Effect of foreign exchange on cash and cash equivalents   (17,861)
Change in cash and cash equivalents   (1,886,871)
Cash and cash equivalents, beginning of year $ 4,917,708 6,804,579
Cash and cash equivalents, ending of year   $ 4,917,708